AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea
· Delayed Price · Currency is KRW 66,500
+3,300 (5.22%)
At close: Mar 6, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 1.55 trillion as of March 6, 2026. Its market cap has increased by 310.13% in one year.
Market Cap
1.55T
Enterprise Value
1.46T
Revenue
8.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
66,500.00
Market Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 1.55T, an increase of 575.65%. That is a compound annual growth rate of 69.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1,552.28B | 21.83% |
| Dec 30, 2025 | 1,274.14B | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qurient | 1,664.89B |
| JS Link | 1,352.82B |
| Inventage Lab | 1,267.98B |
| ROKIT Healthcare | 1,210.28B |
| Rznomics | 2,287.94B |
| Curocell | 763.43B |
| HansBiomed | 695.70B |
| IntoCell | 644.01B |